Registration Options

Activity Dates: 12/24/2019 - 12/19/2022

This course is closed. Please look for other available products in AAPP Education+Resources.

Target Audience

This activity is designed to meet the educational needs of pharmacists and other health care professionals who are interested in or managing the medication of patients with OUD.

Session Summary

During this session, participants will assess the risk for opioid-induced respiratory depression, identify models for overdose education and naloxone distribution, and describe the pharmacology of naloxone. Additionally, the participant will learn how to properly administer naloxone products and how to store and provide medication education to patients.


Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Complete the pre-test before starting the activity.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Participants in this course must complete an examination and achieve a score of 70% or greater. Up to two exam attempts are provided to each participant. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at

Faculty Information and Disclosures

Sarah Melton, PharmD, BCPP, BCACP, FASCP

View biographical information and disclosures

Learning Objectives

  1. Describe validated tools and practice-based methods to assess the risk for opioid-induced respiratory depression.
  2. Identify models for overdose education and naloxone distribution that are applicable to various practice settings.
  3. Discuss Good Samaritan protection provisions for health care providers, first responders, and the layperson.
  4. Describe the pharmacology of naloxone.
  5. Demonstrate appropriate administration of intranasal and intramuscular naloxone products. 
  6. Explain the steps in addressing an opioid overdose emergency.
  7. Discuss cost and appropriate storage of naloxone products.
  8. Provide appropriate education to at-risk patients and laypersons regarding naloxone rescue.

Continuing Education Credit and Disclosures

Activity Dates: 12/24/2019 - 12/19/2022
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-19-073-H08-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Grant Support

This activity is supported by an educational grant from Alkermes, Inc.